Raythink Medical and iFlytek Imaging Forge Strategic Partnership to Empower Precision Healthcare through AI

May 19, 2026 19:00 CST Updated 19:00

RaysightMed

Medical Imaging Product Developer

Xunfei Healthcare

Developer of Intelligent Medical Service Platforms

Recently, RaysightMed and IFLY TEK officially reached a strategic partnership.Both parties will rely on their respective core technologies and resource advantages to deepen collaborative cooperation, break down diagnosis and treatment barriers through AI innovation, optimize service processes, enhance the accuracy and accessibility of diagnosis and treatment, and inject new momentum into the implementation of the "Healthy China 2030" strategy.

As a leading company in cardiovascular functional diagnostics, RaysightMed has adhered to the mission of "protecting the rhythm of life with intelligent technology" since its establishment in 2017, focusing on AI and surgical robotics for precision diagnosis and treatment in cardiovascular and cerebrovascular diseases.Process SolutionCase. With expertise in deep learning algorithms, fluid dynamics simulation, robotics, and other fields, a complete closed-loop diagnosis and treatment system has been established. Breakthrough products such as the RaysightMed Score have been launched. The company holds 13 NMPA certificates and 1 EU CE certificate, with clinical cooperation in over 800 hospitals, becoming a core force driving precision diagnosis and treatment in cardiovascular and cerebrovascular diseases.

The partner in this collaboration, iFlytek Imaging Network (a subsidiary of Xunfei Healthcare), was established in 2015 and focuses on the interconnection and sharing of medical imaging data as well as AI imaging applications. As a national-level high-tech enterprise and a specialized and innovative small-to-medium-sized enterprise in Anhui Province, the company centers around the Anhui Province Imaging Cloud Platform, being the first to connect all medical institutions across the province to achieve imaging interoperability. It has archived over 150 million imaging cases, saving approximately 2 billion yuan annually in imaging examination costs, establishing a leading digital imaging service model in China. Currently, iFlytek Imaging Network is promoting this mature model nationwide, covering the first batch of provincial pilot regions in China, with multiple key projects steadily advancing toward delivery. Its development goals are highly aligned with the innovative vision of RaysightMed.

This strategic partnership represents a precise layout of complementary strengths between the two parties and marks a leap forward in advancing AI healthcare from "single-point breakthroughs" to "collaborative empowerment." According to the plan, the two sides will deepen collaboration by focusing on three core directions:

1. Technological complementarity to strengthen precision diagnosis and treatment.RaysightMed leverages its advantages in AI diagnosis for cardiovascular and cerebrovascular diseases and surgical robotics, combined with IFLY TEK's capabilities in imaging data connectivity, AI-assisted diagnosis, and cloud platform operations, to promote the deep integration of diagnosis and treatment with imaging technology, enhancing diagnostic accuracy and surgical safety.

Second, expand scenarios to enhance medical accessibility.Relying on IFLY TEK's extensive imaging cloud platform and remote service network, combined with RaysightMed's precision diagnosis and treatment products, we will promote the下沉 of high-quality resources, support hierarchical diagnosis and treatment, enable grassroots medical institutions to easily access AI technical support, and benefit more patients.

Third, deepen research and development, and explore new diagnosis and treatment models.Integrate the R&D resources of both parties, focus on the pain points of cardiovascular and cerebrovascular diagnosis and treatment, explore innovative applications of AI in the entire process including imaging diagnosis and surgical navigation, and promote the implementation of more efficient and convenient diagnostic and treatment products.

RaysightMed Founder & CEO Lingxiao Zheng stated: "The development of healthcare cannot be separated from technological innovation and ecosystem collaboration. IFLY TEK's deep expertise in the field of imaging connectivity perfectly complements RaysightMed's precision diagnosis and treatment technology. This collaboration will be patient-centered, making precision medicine accessible to more people and contributing to the realization of the 'Healthy China' vision."

Lu Xiaoliang, Vice President of iFlytek and President of iFlytek Healthcare, stated: "This cooperation between the two parties will realize resource sharing and complementary advantages, promote the coordinated development of imaging and cardiovascular & cerebrovascular diagnosis and treatment, explore a new model of 'AI + healthcare,' and inject new vitality into the high-quality development of the medical industry."

Technology Empowers Healthcare, Collaboration Builds the Future. This strategic cooperation is not only an important measure of the strong alliance between the two parties but also a vivid manifestation of collaborative innovation in the AI healthcare industry. In the future, both parties will adhere to the original intention of healthcare, focus on innovation, promote technology integration and service upgrades, protect people's lives and health with intelligent technology, and jointly draw a new chapter of high-quality development in the healthcare industry!